BackInter Pharma Public Company Limited Overview

Inter Pharma Public Company Limited Long Term Debt

Track Inter Pharma Public Company Limited's long-term debt ($170M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$168.49M
↓ 21.74% YoYΔ $-46.80M vs prior year quarter

Peer trimmed avg / median

Loading

Inter Pharma Public Company Limited Long Term Debt History

Loading

Inter Pharma Public Company Limited vs. peers: Long Term Debt Comparison

Loading

Inter Pharma Public Company Limited Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Inter Pharma Public Company Limited (IP.BK) FAQ

Inter Pharma Public Company Limited (IP.BK) currently reports a long-term debt of $170M as of June 2026. That compares with $220M in the prior-year period — down 21.7% year over year. Use the charts on this page to explore Inter Pharma Public Company Limited's long-term debt history and peer comparisons.

Inter Pharma Public Company Limited's long-term debt decreased from $220M to $170M — a 21.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inter Pharma Public Company Limited reported $170M in long-term debt as of June 2026. That compares with $220M in the prior-year period — down 21.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inter Pharma Public Company Limited, and consider following IP.BK for alerts when major investors trade the stock.

Inter Pharma Public Company Limited is classified in the Healthcare sector. On long-term debt, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IP.BK with unrelated industries.

Questions & Answers